Clinical Trials
2 trialsNCT03975036 2019-06-05
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
Henan Cancer Hospital
Phase 2/3 Unknown
NCT03929965 2019-04-29
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Shanghai Changzheng Hospital
Phase NA Unknown